Stay updated on Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The webpage has updated its last update dates to February 2025, indicating a shift in the timeline for content relevance.
    Difference
    1%
    Check dated 2025-03-03T22:16:05.000Z thumbnail image
  3. Check
    28 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.7%
    Check dated 2025-02-10T09:32:58.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.0%
    Check dated 2025-02-03T05:41:01.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.0 to v2.14.1.
    Difference
    0.0%
    Check dated 2025-01-19T20:03:48.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.1%
    Check dated 2025-01-12T17:03:27.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    The website has added new registry identifiers and updated to revision v2.13.3, while removing older entries and the previous revision v2.13.2.
    Difference
    0.5%
    Check dated 2024-12-14T12:25:30.000Z thumbnail image

Stay in the know with updates to Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.